| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 27 | 2021 | 386 | 4.88 | Why? |
| HIV Antibodies | 30 | 2021 | 776 | 3.61 | Why? |
| AIDS Vaccines | 14 | 2021 | 452 | 2.50 | Why? |
| HIV-1 | 34 | 2021 | 3365 | 2.48 | Why? |
| Protein Multimerization | 24 | 2021 | 1336 | 1.81 | Why? |
| Cryoelectron Microscopy | 11 | 2020 | 2372 | 1.60 | Why? |
| Antibodies, Neutralizing | 52 | 2021 | 25288 | 1.44 | Why? |
| Epitopes | 28 | 2021 | 4113 | 1.40 | Why? |
| Ebolavirus | 7 | 2019 | 834 | 1.28 | Why? |
| Protein Structure, Secondary | 4 | 2018 | 1077 | 1.21 | Why? |
| Glycoproteins | 6 | 2020 | 615 | 1.07 | Why? |
| CD4 Antigens | 5 | 2017 | 306 | 1.00 | Why? |
| HIV Antigens | 3 | 2018 | 102 | 0.83 | Why? |
| Coenzymes | 1 | 2019 | 19 | 0.80 | Why? |
| Ion Channels | 2 | 2018 | 167 | 0.79 | Why? |
| Protein Stability | 6 | 2018 | 756 | 0.78 | Why? |
| Proteolysis | 4 | 2018 | 751 | 0.73 | Why? |
| Filoviridae | 1 | 2018 | 70 | 0.71 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2019 | 239 | 0.70 | Why? |
| Nucleoproteins | 1 | 2019 | 223 | 0.67 | Why? |
| HIV Infections | 18 | 2021 | 11620 | 0.67 | Why? |
| Macromolecular Substances | 1 | 2017 | 103 | 0.66 | Why? |
| Polysaccharides | 7 | 2020 | 854 | 0.64 | Why? |
| HIV Envelope Protein gp120 | 5 | 2019 | 267 | 0.62 | Why? |
| Antibodies, Monoclonal | 14 | 2021 | 8041 | 0.60 | Why? |
| Rabbits | 13 | 2021 | 1171 | 0.58 | Why? |
| Protein Domains | 11 | 2021 | 6563 | 0.58 | Why? |
| Nucleocapsid | 1 | 2019 | 734 | 0.54 | Why? |
| Spike Glycoprotein, Coronavirus | 15 | 2021 | 37182 | 0.52 | Why? |
| HEK293 Cells | 18 | 2021 | 8394 | 0.47 | Why? |
| Hemorrhagic Fever, Ebola | 6 | 2018 | 1475 | 0.47 | Why? |
| Protein Binding | 22 | 2021 | 11430 | 0.47 | Why? |
| Image Processing, Computer-Assisted | 2 | 2017 | 1383 | 0.46 | Why? |
| Glycosylation | 10 | 2021 | 1255 | 0.43 | Why? |
| Crystallography, X-Ray | 11 | 2020 | 2689 | 0.43 | Why? |
| Receptors, Virus | 6 | 2021 | 5659 | 0.42 | Why? |
| Protein Structure, Quaternary | 5 | 2018 | 455 | 0.42 | Why? |
| Binding Sites | 13 | 2021 | 6201 | 0.42 | Why? |
| HIV | 1 | 2017 | 1116 | 0.41 | Why? |
| Models, Molecular | 14 | 2019 | 7616 | 0.41 | Why? |
| Ion Channel Gating | 2 | 2018 | 22 | 0.38 | Why? |
| Microscopy, Electron | 4 | 2018 | 830 | 0.36 | Why? |
| HIV Envelope Protein gp41 | 3 | 2018 | 153 | 0.36 | Why? |
| Protein Conformation | 9 | 2020 | 4386 | 0.36 | Why? |
| Recombinant Proteins | 11 | 2020 | 3786 | 0.36 | Why? |
| HIV Envelope Protein gp160 | 2 | 2017 | 33 | 0.36 | Why? |
| Protein Interaction Domains and Motifs | 7 | 2020 | 2134 | 0.35 | Why? |
| Protein Conformation, alpha-Helical | 3 | 2019 | 530 | 0.35 | Why? |
| SARS Virus | 6 | 2021 | 13021 | 0.35 | Why? |
| Antibodies, Viral | 20 | 2021 | 51949 | 0.34 | Why? |
| Protein Processing, Post-Translational | 3 | 2018 | 634 | 0.31 | Why? |
| Ebola Vaccines | 2 | 2017 | 126 | 0.30 | Why? |
| Amino Acid Sequence | 10 | 2020 | 6049 | 0.30 | Why? |
| Sequence Homology, Amino Acid | 2 | 2019 | 945 | 0.29 | Why? |
| Animals | 37 | 2021 | 78931 | 0.28 | Why? |
| Solubility | 4 | 2017 | 382 | 0.28 | Why? |
| Cross Reactions | 10 | 2021 | 4374 | 0.27 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.27 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2018 | 511 | 0.26 | Why? |
| Epitope Mapping | 5 | 2020 | 1240 | 0.25 | Why? |
| Antigens, Viral | 5 | 2021 | 6298 | 0.24 | Why? |
| Macaca mulatta | 4 | 2021 | 3716 | 0.24 | Why? |
| Viral Proteins | 3 | 2020 | 7370 | 0.23 | Why? |
| Drug Design | 3 | 2018 | 2627 | 0.22 | Why? |
| Structure-Activity Relationship | 5 | 2019 | 2219 | 0.22 | Why? |
| Mice | 16 | 2021 | 21357 | 0.22 | Why? |
| Viral Nonstructural Proteins | 1 | 2019 | 4810 | 0.22 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.21 | Why? |
| Amino Acid Substitution | 2 | 2017 | 1706 | 0.20 | Why? |
| Conserved Sequence | 2 | 2020 | 751 | 0.20 | Why? |
| Epitopes, B-Lymphocyte | 5 | 2020 | 1267 | 0.20 | Why? |
| Binding Sites, Antibody | 2 | 2021 | 466 | 0.20 | Why? |
| Voltage-Dependent Anion Channels | 1 | 2018 | 3 | 0.19 | Why? |
| Mechanotransduction, Cellular | 1 | 2018 | 28 | 0.19 | Why? |
| Crystallography | 1 | 2018 | 52 | 0.19 | Why? |
| CHO Cells | 5 | 2018 | 831 | 0.19 | Why? |
| Macaca fascicularis | 2 | 2021 | 1009 | 0.19 | Why? |
| Cross Protection | 1 | 2021 | 373 | 0.18 | Why? |
| Heparitin Sulfate | 1 | 2020 | 285 | 0.18 | Why? |
| Pliability | 1 | 2017 | 36 | 0.18 | Why? |
| Cricetulus | 5 | 2018 | 936 | 0.18 | Why? |
| Adjuvants, Immunologic | 2 | 2018 | 1709 | 0.18 | Why? |
| Anions | 1 | 2017 | 23 | 0.18 | Why? |
| Trypsin | 1 | 2018 | 209 | 0.17 | Why? |
| Promoter Regions, Genetic | 2 | 2018 | 823 | 0.17 | Why? |
| Antigens, Protozoan | 1 | 2017 | 121 | 0.17 | Why? |
| Complementarity Determining Regions | 4 | 2020 | 147 | 0.17 | Why? |
| Antibodies, Protozoan | 1 | 2017 | 121 | 0.17 | Why? |
| Guinea Pigs | 4 | 2018 | 420 | 0.17 | Why? |
| Protein Structure, Tertiary | 3 | 2017 | 1565 | 0.17 | Why? |
| Pattern Recognition, Automated | 1 | 2017 | 160 | 0.16 | Why? |
| Malaria Vaccines | 1 | 2017 | 90 | 0.16 | Why? |
| Protein Subunits | 2 | 2018 | 755 | 0.16 | Why? |
| Protozoan Proteins | 1 | 2017 | 205 | 0.16 | Why? |
| B-Lymphocytes | 6 | 2021 | 4418 | 0.16 | Why? |
| Cell Line | 8 | 2021 | 12040 | 0.16 | Why? |
| Proline | 1 | 2018 | 345 | 0.16 | Why? |
| N-Acetylneuraminic Acid | 1 | 2018 | 198 | 0.16 | Why? |
| Immunization | 7 | 2018 | 2019 | 0.16 | Why? |
| Antigen-Antibody Reactions | 2 | 2018 | 616 | 0.16 | Why? |
| Plant Lectins | 1 | 2017 | 114 | 0.16 | Why? |
| Virus Internalization | 4 | 2020 | 7921 | 0.15 | Why? |
| Viral Fusion Proteins | 1 | 2020 | 399 | 0.15 | Why? |
| Gene Expression | 4 | 2019 | 3332 | 0.15 | Why? |
| Mice, Inbred BALB C | 7 | 2021 | 5814 | 0.15 | Why? |
| Glycine | 1 | 2017 | 203 | 0.15 | Why? |
| Membrane Proteins | 2 | 2018 | 1733 | 0.15 | Why? |
| Cloning, Molecular | 1 | 2019 | 1036 | 0.15 | Why? |
| Nucleic Acid Conformation | 1 | 2019 | 621 | 0.15 | Why? |
| Sequence Alignment | 2 | 2019 | 2109 | 0.15 | Why? |
| Mutagenesis | 1 | 2017 | 394 | 0.15 | Why? |
| Influenza A virus | 2 | 2018 | 2234 | 0.15 | Why? |
| Mutation | 7 | 2021 | 12376 | 0.14 | Why? |
| Surface Plasmon Resonance | 1 | 2017 | 440 | 0.14 | Why? |
| Lymphokines | 1 | 2014 | 13 | 0.14 | Why? |
| Humans | 63 | 2021 | 930598 | 0.14 | Why? |
| Mycoplasma | 1 | 2014 | 36 | 0.14 | Why? |
| Immunoglobulin Fab Fragments | 4 | 2020 | 556 | 0.14 | Why? |
| Germinal Center | 1 | 2017 | 332 | 0.14 | Why? |
| Plasmodium falciparum | 1 | 2017 | 337 | 0.13 | Why? |
| Immune Evasion | 3 | 2021 | 2081 | 0.13 | Why? |
| Malaria, Falciparum | 1 | 2017 | 377 | 0.12 | Why? |
| Immunoglobulin Variable Region | 1 | 2014 | 253 | 0.12 | Why? |
| Genetic Vectors | 1 | 2019 | 1600 | 0.11 | Why? |
| Ferrets | 4 | 2018 | 1201 | 0.11 | Why? |
| Antigens | 1 | 2014 | 267 | 0.11 | Why? |
| Mutation, Missense | 1 | 2017 | 863 | 0.11 | Why? |
| Membrane Fusion | 1 | 2016 | 713 | 0.11 | Why? |
| Neutralization Tests | 6 | 2021 | 6698 | 0.11 | Why? |
| RNA, Viral | 1 | 2019 | 32276 | 0.11 | Why? |
| Peptide Hydrolases | 1 | 2018 | 1269 | 0.11 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.11 | Why? |
| Vero Cells | 7 | 2021 | 14117 | 0.11 | Why? |
| Viral Tropism | 1 | 2018 | 1329 | 0.10 | Why? |
| Single-Domain Antibodies | 1 | 2017 | 744 | 0.10 | Why? |
| Antigenic Variation | 2 | 2021 | 249 | 0.10 | Why? |
| 3T3 Cells | 2 | 2021 | 152 | 0.10 | Why? |
| Proteins | 1 | 2017 | 921 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2020 | 8843 | 0.10 | Why? |
| Membrane Glycoproteins | 1 | 2018 | 2273 | 0.09 | Why? |
| Antibody Specificity | 3 | 2018 | 1328 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.09 | Why? |
| Madin Darby Canine Kidney Cells | 2 | 2021 | 640 | 0.08 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2021 | 12361 | 0.08 | Why? |
| Coronavirus | 1 | 2016 | 18339 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Mutagenesis, Site-Directed | 2 | 2017 | 449 | 0.08 | Why? |
| Anti-HIV Agents | 1 | 2019 | 2209 | 0.08 | Why? |
| Immunoglobulin A | 1 | 2018 | 3567 | 0.08 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.07 | Why? |
| Bacterial Proteins | 1 | 2014 | 1318 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.07 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.07 | Why? |
| Protein Engineering | 2 | 2017 | 536 | 0.07 | Why? |
| HeLa Cells | 2 | 2018 | 1303 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2017 | 4624 | 0.06 | Why? |
| Dogs | 2 | 2021 | 2529 | 0.06 | Why? |
| N-Acetylglucosaminyltransferases | 1 | 2021 | 16 | 0.06 | Why? |
| Antibody Formation | 3 | 2018 | 4038 | 0.05 | Why? |
| Female | 15 | 2021 | 380317 | 0.05 | Why? |
| Lassa virus | 1 | 2020 | 99 | 0.05 | Why? |
| Crystallization | 1 | 2020 | 331 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2020 | 3608 | 0.05 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.05 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2020 | 222 | 0.05 | Why? |
| Biophysical Phenomena | 1 | 2018 | 78 | 0.05 | Why? |
| Osmolar Concentration | 1 | 2018 | 86 | 0.05 | Why? |
| Immunoglobulin G | 4 | 2018 | 21571 | 0.05 | Why? |
| Drosophila | 1 | 2018 | 55 | 0.05 | Why? |
| Carbohydrate Sequence | 1 | 2018 | 54 | 0.05 | Why? |
| Arabidopsis | 1 | 2018 | 88 | 0.05 | Why? |
| Repetitive Sequences, Amino Acid | 1 | 2017 | 37 | 0.05 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.05 | Why? |
| B-Lymphocyte Subsets | 1 | 2020 | 372 | 0.05 | Why? |
| Cross-Linking Reagents | 1 | 2018 | 91 | 0.04 | Why? |
| Jurkat Cells | 1 | 2018 | 273 | 0.04 | Why? |
| Viral Vaccines | 2 | 2017 | 7560 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Musa | 1 | 2017 | 13 | 0.04 | Why? |
| Gene Knock-In Techniques | 1 | 2017 | 124 | 0.04 | Why? |
| Chick Embryo | 1 | 2018 | 249 | 0.04 | Why? |
| Models, Animal | 1 | 2021 | 788 | 0.04 | Why? |
| Gadolinium | 1 | 2018 | 318 | 0.04 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 159 | 0.04 | Why? |
| THP-1 Cells | 1 | 2018 | 374 | 0.04 | Why? |
| Multigene Family | 1 | 2018 | 377 | 0.04 | Why? |
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 94 | 0.04 | Why? |
| Cell Surface Display Techniques | 1 | 2017 | 170 | 0.04 | Why? |
| Genome, Viral | 1 | 2019 | 13157 | 0.04 | Why? |
| Cell Lineage | 1 | 2018 | 241 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.04 | Why? |
| Liposomes | 1 | 2018 | 334 | 0.04 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 349 | 0.04 | Why? |
| Protein Conformation, beta-Strand | 1 | 2017 | 414 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 382 | 0.04 | Why? |
| Chromatography, Affinity | 1 | 2018 | 310 | 0.04 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.04 | Why? |
| Amino Acid Motifs | 1 | 2018 | 620 | 0.04 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.04 | Why? |
| Single-Chain Antibodies | 1 | 2018 | 259 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.04 | Why? |
| Population Groups | 1 | 2017 | 212 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2017 | 647 | 0.04 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.04 | Why? |
| Immunoglobulin lambda-Chains | 1 | 2014 | 6 | 0.04 | Why? |
| Immunoglobulin kappa-Chains | 1 | 2014 | 12 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| In Vitro Techniques | 1 | 2018 | 1027 | 0.03 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.03 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 497 | 0.03 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2017 | 801 | 0.03 | Why? |
| Antiviral Agents | 2 | 2018 | 41703 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.03 | Why? |
| Primates | 1 | 2017 | 584 | 0.03 | Why? |
| Vaccines, Virus-Like Particle | 1 | 2017 | 312 | 0.03 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.03 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 572 | 0.03 | Why? |
| Immune Sera | 1 | 2018 | 884 | 0.03 | Why? |
| Immunodominant Epitopes | 1 | 2018 | 813 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 7868 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.03 | Why? |
| Coronaviridae | 1 | 2017 | 923 | 0.03 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.03 | Why? |
| Cricetinae | 1 | 2018 | 3344 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.02 | Why? |
| Camelus | 1 | 2017 | 1425 | 0.02 | Why? |
| Swine Diseases | 1 | 2018 | 1219 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2013 | 3198 | 0.02 | Why? |
| Lymphocyte Activation | 1 | 2017 | 2742 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.02 | Why? |
| Male | 6 | 2021 | 367725 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2019 | 6902 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.02 | Why? |
| Vaccination | 2 | 2017 | 19050 | 0.01 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.01 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.01 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Adult | 2 | 2020 | 244371 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Aged | 1 | 2020 | 215776 | 0.00 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.00 | Why? |